Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Akoya Biosciences, Inc.

Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Participate at Three Upcoming Investor Conferences
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Participate at Two Upcoming Investor Conferences
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Announces Pricing of Public Offering of Common Stock
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Announces Public Offering of Common Stock
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Marks Milestone Achievement with Shipment of 1,000th Spatial Biology Instrument
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Introduces PhenoCode Discovery Panels to Simplify PhenoCycler-Fusion Workflow
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences and Enable Medicine Introduce Cloud Platform to Power Faster Analysis of PhenoCycler-Fusion Data
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Report First Quarter 2023 Financial Results on May 8th, 2023
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Announces Leadership Transition
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Reports Record Revenue in the Fourth Quarter of 2022 and Provides Full Year 2023 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Announces Appointment of Jennifer Kamocsay as General Counsel
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Report Fourth Quarter and Full Year 2022 Financial Results on March 6th, 2023 and Participate at Two Upcoming Investor Conferences
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences to Present First-of-its-Kind Spatial Multiomics Dataset at 2023 AGBT General Meeting
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2022
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Participate at 41st Annual J.P. Morgan Healthcare Conference
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Reports Record Revenue with 40% YoY Growth in the Third Quarter and Raises Full Year 2022 Revenue Guidance
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya Biosciences Launches PhenoCode Signature Panels to Accelerate Development of Predictive Biomarkers for Cancer Immunotherapy
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Participate at Three Upcoming Investor Conferences
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Akoya to Report Third Quarter 2022 Financial Results on November 7th, 2022
From Akoya Biosciences, Inc.
Via GlobeNewswire
Tickers AKYA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.